Vaxart (VXRT) Announces $3 Million ODP jump from $1.65 to $5.00! will this be the next $BPTH pump?
why the jump?
Amazing new coming from the old $AVIR which had a split... many of us long still hold the price tag of $7-$8.00.. this is one of my weapon to cont. my trading career into the next level. I believe this will run to $7+ like how October was but many believe it might bet he next $BPTH pump due to the volume increase. We got to understand why this happen? I believe a huge new will come! after-hours also look nice.
Vaxart, Inc. (NASDAQ:VXRT) rose to $2.48. It was reported on Mar, 19 by Barchart.com. It has $17.71M MC. The company’s valuation will be $1.59M more at $2.70 target.For more Vaxart, Inc. (NASDAQ:VXRT) news published briefly go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Businesswire.com or Seekingalpha.com. The titles are as follows: “Vaxart up 12% – Seeking Alpha” published on September 20, 2018, “Vaxart’s teslexivir flunks mid-stage condyloma study; shares down 28% premarket – Seeking Alpha” on June 04, 2018, “SDRL, SBGL and CRBP among premarket gainers – Seeking Alpha” with a publish date: March 19, 2019, “Vaxart to Present at World Vaccine and Immunotherapy Congress West Coast 2018 – Business Wire” and the last “Adial Pharmaceuticals and Tonix Pharmaceuticals among Healthcare gainers; Restoration Robotics and Vaxart among losers – Seeking Alpha” with publication date: November 29, 2018.Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform.The company has $17.71 million market cap. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus vaccines, as well as other recombinant vaccines.Currently it has negative earnings. The Company’s development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV.
- $3million Registered Directed Priced at the market
- Email Alert
Amazing new coming from the old $AVIR which had a split... many of us long still hold the price tag of $7-$8.00.. this is one of my weapon to cont. my trading career into the next level. I believe this will run to $7+ like how October was but many believe it might bet he next $BPTH pump due to the volume increase. We got to understand why this happen? I believe a huge new will come! after-hours also look nice.
Comments